- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1 IPO registration
- 5.1 Opinion of Pryor Cashman LLP
- 10.24 Amended and Restated Promissory Note, Dated September 2020, Issued to KBL IV Sponsor LLC
- 10.25 Convertible Promissory Note, Dated September 2020, Issued to KBL IV Sponsor LLC
- 23.1 Consent of Withumsmith+brown, PC, Independent Registered Public Accounting Firm
- 23.2 Consents of Marcum LLP, Independent Registered Public Accounting Firm.
- 99.1 Consent of James N. Woody, M.D., PH.D., As Designee to the Board of Directors
- 99.2 Consent of Sir Marc Feldmann, PH.D., As Designee to the Board of Directors
- 99.3 Consent of Lawrence Steinman, M.D., As Designee to the Board of Directors
- 99.4 Consent of Prof. Richard W. Barker As Designee to the Board of Directors
- 99.5 Consent of Larry Gold, PH.D., As Designee to the Board of Directors
- 99.6 Consent of Donald A. Mcgovern, JR., As Designee to the Board of Directors
- 99.7 Consent of Shoshana Shendelman, PH.D., As Designee to the Board of Directors
- 9 May 22 AW Withdrawal of amendment
- 6 Apr 22 POS AM Prospectus update (post-effective amendment)
- 6 Apr 22 424B3 Prospectus supplement
- 25 Aug 21 424B4 Prospectus supplement with pricing info
- 25 Aug 21 EFFECT Notice of effectiveness
- 19 Aug 21 POS AM Prospectus update (post-effective amendment)
- 2 Aug 21 POS AM Prospectus update (post-effective amendment)
- 3 Nov 20 EFFECT Notice of effectiveness
- 2 Nov 20 424B4 Prospectus supplement with pricing info
-
19 Oct 20 S-1 IPO registration
Exhibit 99.3
October 2, 2020
KBL Merger Corp. IV
30 Park Place, Suite 45E
New York, NY 10007
Consent to Reference in Registration Statement
KBL Merger Corp. IV, a Delaware corporation (the “Company”), is filing a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Securities Act”), as of the date hereof. In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the prospectus included in such registration statement, as well as the prospectus included in any other registration statement (or any amendment of supplement thereto) that is being filed by the Company with the SEC contemporaneously with the Form S-1 (or any amendment or supplement thereto), and as well as any other related public announcement by the Company, as a future member of the board of directors of the Company.
Sincerely,
/s/ Lawrence Steinman, M.D.
Lawrence Steinman, M.D.